VEXRX | VLEIX | VEXRX / VLEIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 9 years | - |
Gain YTD | 12.651 | 19.219 | 66% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 50000 | 100000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 22B | 743M | 2,961% |
Annual Yield % from dividends | 0.58 | 0.00 | - |
Returns for 1 year | 26.37 | 29.53 | 89% |
Returns for 3 years | -20.66 | 3.57 | -579% |
Returns for 5 years | 18.31 | 21.35 | 86% |
Returns for 10 years | 18.71 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PFIEX | 11.55 | -0.07 | -0.60% |
Principal International Equity Index R6 | |||
VWENX | 80.41 | -0.67 | -0.83% |
Vanguard Wellington™ Admiral™ | |||
IHOTX | 19.42 | -0.21 | -1.07% |
Hartford International Opportunities R5 | |||
FAERX | 32.71 | -0.42 | -1.27% |
Fidelity Advisor Overseas M | |||
RYOAX | 61.01 | -2.83 | -4.43% |
Rydex Biotechnology H |